Jaguar Health, Inc.'s (JAGX) CEO Lisa Conte on Q2 2022 Results - Earnings Call Transcript

Jaguar Health, Inc. (NASDAQ:NASDAQ:JAGX) Q2 2022 Earnings Conference Call August 22, 2022 8:30 A.M.

Related Keywords

United States ,New York ,Qatar ,Milan ,Lombardia ,Italy ,Dubai ,Dubayy ,United Arab Emirates ,Kuwait ,China ,Saudi Arabia ,Bahrain ,Woman ,Americans ,American ,Quadri Pharma ,Napo Thera ,Lisa Conte ,Carol Lizak ,Kian Wendt ,Company Participants ,Jaguar Health Inc ,Nasdaq ,American Pet Products Association ,Filament Health ,Us National Canine Cancer Ministry ,Synworld Technologies Corporation ,Jaguar Health ,United States Napo Pharmaceuticals ,Jaguar Health Founder ,Jaguar Entheogen Therapeutics Initiative ,National Institute Of Allergies ,Market Research ,Jaguar Health Canine Cancer Take ,European Medicines Agency ,Vision Research ,Conference Call August ,Chief Executive ,Investor Relations ,United States Napo ,Napo Therapeutics ,Chief Financial Officer ,Chief Commercial ,Veterinary Medicine ,Allied Market ,National Institute ,Infectious Diseases ,Canine Cancer Ministry ,Cancer Care Index ,Canada Based Synworld Technologies Corporation ,Entheogen Therapeutics Initiative ,